The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 05, 2017
Filed:
Nov. 09, 2016
Millennium Pharmaceuticals, Inc., Cambridge, MA (US);
Indu T. Bharathan, Cambridge, MA (US);
Chris Blackburn, Natick, MA (US);
Jeffrey P. Ciavarri, Reading, MA (US);
Jouhara Chouitar, Stoughton, MA (US);
Courtney A. Cullis, Bedford, MA (US);
Natalie D'Amore, Lynnfield, MA (US);
Paul E. Fleming, Wellesley, MA (US);
Kenneth M. Gigstad, Westford, MA (US);
Krista E. Gipson, Medford, MA (US);
Mario Girard, Quincy, MA (US);
Yongbo Hu, Winchester, MA (US);
Janice Lee, Cambridge, MA (US);
Gang Li, Westborough, MA (US);
Mansoureh Rezaei, Quincy, MA (US);
Michael D. Sintchak, Winchester, MA (US);
Francois Soucy, Stoneham, MA (US);
Stephen G. Stroud, Medford, MA (US);
Tricia J. Vos, Boston, MA (US);
Tzu-Tshin Wong, Acton, MA (US);
He Xu, Needham, MA (US);
Tianlin Xu, Shrewsbury, MA (US);
Yingchun Ye, Belmont, MA (US);
Millennium Pharmaceuticals, Inc., Cambridge, MA (US);
Abstract
The present invention provides a compound of formula I: and pharmaceutically acceptable salts thereof, wherein X, R, R, R, R, R, L, L, m, and n, are as described in the specification. Such compounds are inhibitors of VPS34 and thus useful for treating proliferative, inflammatory, or cardiovascular disorders.